Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Joseph McCune

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosusDacheng Ding, Hemal Mehta, W Joseph McCune, et al.
The Journal of Rheumatology|July 15, 2003
Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosusMona M Riskalla, Emily C Somers, Richard A Fatica, et al.
Current Opinion in Rheumatology|February 13, 2019
Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndromeAndrew P Vreede, Paula L Bockenstedt, W Joseph McCune, et al.
The New England Journal of Medicine|September 8, 2010
Clinical problem-solving. Thinking inside the boxPeter Jessel, Nasia Safdar, W Joseph McCune, et al.
Arthritis and Rheumatism|September 6, 2005
Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupusEmily C Somers, Wendy Marder, Gregory M Christman, et al.
The Oncologist|June 28, 2008
Response to "Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury"Emily C Somers, Gregory M Christman, Senait Fisseha, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosusEmily C Somers, Wendy Marder, Mariana J Kaplan, et al.
Arthritis Care & Research|August 5, 2015
Utility and Associated Risk of Pulmonary Embolism Computed Tomography Scans in the Michigan Lupus CohortRuba Kado, Emily Siegwald, Emily Lewis, et al.
Clinical Immunology (Orlando, Fla.)|August 22, 2013
The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosusWenpu Zhao, Celine C Berthier, Emily E Lewis, et al.
JCI Insight|October 27, 2020
A longitudinal and transancestral analysis of DNA methylation patterns and disease activity in lupus patientsPatrick Coit, Lourdes Ortiz-Fernandez, Emily E Lewis, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosusDacheng Ding, Hemal Mehta, W Joseph McCune, et al.
The Journal of Rheumatology|July 15, 2003
Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosusMona M Riskalla, Emily C Somers, Richard A Fatica, et al.
Current Opinion in Rheumatology|February 13, 2019
Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndromeAndrew P Vreede, Paula L Bockenstedt, W Joseph McCune, et al.
The New England Journal of Medicine|September 8, 2010
Clinical problem-solving. Thinking inside the boxPeter Jessel, Nasia Safdar, W Joseph McCune, et al.
Arthritis and Rheumatism|September 6, 2005
Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupusEmily C Somers, Wendy Marder, Gregory M Christman, et al.
The Oncologist|June 28, 2008
Response to "Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury"Emily C Somers, Gregory M Christman, Senait Fisseha, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosusEmily C Somers, Wendy Marder, Mariana J Kaplan, et al.
Arthritis Care & Research|August 5, 2015
Utility and Associated Risk of Pulmonary Embolism Computed Tomography Scans in the Michigan Lupus CohortRuba Kado, Emily Siegwald, Emily Lewis, et al.
Clinical Immunology (Orlando, Fla.)|August 22, 2013
The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosusWenpu Zhao, Celine C Berthier, Emily E Lewis, et al.
JCI Insight|October 27, 2020
A longitudinal and transancestral analysis of DNA methylation patterns and disease activity in lupus patientsPatrick Coit, Lourdes Ortiz-Fernandez, Emily E Lewis, et al.
Pageof 9